Curing Cancer

Part of the Cancer Treatment and Research book series (CTAR, volume 154)


The panacea everyone is searching for may actually be a conquest of rather than a cure for cancer.


Stem Cell Cancer Stem Cell Acute Promyelocytic Leukemia Arsenic Trioxide Normal Stem Cell 


  1. 1.
    Leaf C (2004) Why we’re losing the war on cancer (and how to win it) (Avastin, Erbitux, Gleevec...the new wonder drugs might make you think we’re finally beating this dreaded scourge. We’re not. Here’s how to turn the fight around.) Fortune Magazine March 22, 2004, pp 77–92Google Scholar
  2. 2.
    Jemal A, Siegel R, Ward E et al (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66CrossRefPubMedGoogle Scholar
  3. 3.
    Ebos JML, Lee CR, Cruz-Munoz W et al (2009) Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15:232–239CrossRefPubMedGoogle Scholar
  4. 4.
    Pàez-Ribes M, Allen E, Hudock J et al (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15:220–231CrossRefPubMedGoogle Scholar
  5. 5.
    Yilmaz ÖH, Valdez R, Theisen BK et al (2006) Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441:475–482CrossRefPubMedGoogle Scholar
  6. 6.
    Lin S-H, Lee Y-C, Choueiri MB et al (2008) Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer. Clin Cancer Res 14:3729–3736CrossRefPubMedGoogle Scholar
  7. 7.
    Mickisch GH, Garin A, van Poppel H et al (2001) Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358:966–970CrossRefPubMedGoogle Scholar
  8. 8.
    Flanigan RC, Salmon SE, Blumenstein BA et al (2001) Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 345:1655–1659CrossRefPubMedGoogle Scholar
  9. 9.
    Rapiti EJ, Verkooijen HM, Vlastos G et al (2006) Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 24:2743–2749CrossRefPubMedGoogle Scholar
  10. 10.
    Tu S-M, Lopez A, Leibovici D et al (2009) Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy. Cancer 115:2872–2880CrossRefPubMedGoogle Scholar
  11. 11.
    Tu S-M, Millikan RE, Mengistu B et al (2001) Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. Lancet 357:336–341, Erratum in: Lancet 2001;357(9263):1210CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.The University of Texas M. D. Anderson Cancer CenterHoustonUSA

Personalised recommendations